Is DNAH1 p.Lys415Arg (c.1244A>G) pathogenic?

DNAH1 p.Lys415Arg (c.1244A>G) is classified Benign/Likely benign in DNAH1 (ClinVar, Multiple submitters, 5 submitters; last evaluated 2026-01-27). AlphaMissense: likely benign (0.0812); Low-frequency (popmax 2.33%, sas); Associated with spermatogenic failure 18.

What condition is associated with DNAH1 p.Lys415Arg (c.1244A>G)?

DNAH1 p.Lys415Arg (c.1244A>G) is associated with spermatogenic failure 18, ciliary dyskinesia, primary, 37 (ClinVar).

How common is DNAH1 p.Lys415Arg (c.1244A>G) in the general population?

DNAH1 p.Lys415Arg (c.1244A>G) is low-frequency (popmax 2.33%, sas) (gnomAD).

What do computational predictors say about DNAH1 p.Lys415Arg (c.1244A>G)?

AlphaMissense predicts likely benign (score 0.0812) — an in-silico prediction, not a clinical call.

DNAH1 p.Lys415Arg

c.1244A>G · rs61729402 · VCV478409

Benign/Likely benign Multiple submitters

Classification

Benign/Likely benign

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 5 submitters

AlphaMissense

likely benign

0.0812 · ACMG-weighted

gnomAD v4.1

Rare

low-frequency (popmax 2.33%, sas)

Missense predictors

0/2 damaging

AlphaMissense, REVEL

Conditions

spermatogenic failure 18

Computational evidence

Protein change
AlphaMissense	0.0812	likely benign
REVEL	0.079	moderately benign-leaning
⇒ AlphaMissense and REVEL both call this tolerated.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 5.5	GERP 0.77, phastCons 1
Regional constraint	o/e 1.04	unconstrained · MANE · 30 kb · p 0.21 · regional, not allelic
Overall
CADD	17.52	PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 2.33% South Asian · 2,118/91,086 alleles

Filtering AF 2.24% ClinGen BA1/BS1 input FAF95, joint · FAF99 2.21%

Overall 0.568% 9,164/1,613,982 alleles · low-frequency

Ancestry group	Frequency	1 in
South Asiangrpmax	2.33%	43
East Asian	0.72%	139
Remaining individualsnot grpmax-eligible	0.559%	179
Middle Eastern	0.511%	196
European (non-Finnish)	0.508%	197
Admixed American	0.248%	403
Ashkenazi Jewishnot grpmax-eligible	0.165%	604
Finnishnot grpmax-eligible	0.149%	673
African / African-American	0.0786%	1,272

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: DNAH1
Protein: p.Lys415Arg
Coding: c.1244A>G
MANE Select: NM_015512
dbSNP: rs61729402
Type: single nucleotide variant
Location: chr3:52332352 (GRCh38)
Gene constraint: LOEUF 0.759 · pLI <0.01 (gnomAD)
Residue 415: the 'stem' region

Full DNAH1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

spermatogenic failure 18 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: ciliary dyskinesia, primary, 37

Similar variants

DNAH1 c.1034-2A>G Likely pathogenic ★★ same condition
DNAH1 c.10474+1G>A Pathogenic/Likely pathogenic ★★ same condition
DNAH1 c.10968+2C>T Likely pathogenic ★★ same condition
DNAH1 c.5244+1G>A Likely pathogenic ★★ same condition
DNAH1 p.Arg1702Ter Pathogenic ★★ same condition
DNAH1 p.Arg2479Ter Pathogenic/Likely pathogenic ★★ same condition
DNAH1 p.Arg2622Ter Pathogenic/Likely pathogenic ★★ same condition
DNAH1 p.Arg2724Ter Pathogenic ★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dnah1-p-lys415arg (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown